2m 2m 2m 2m 2m 2m 2m
Regeneron Pharma (REGN)
NASDAQ
$837.50+$3.46 (+0.41%)
Price as of Aug 21, 2026 7:58 PM EDT- $83.6BMarket Cap
- 42.21%1-Year Change
- BiotechnologyIndustry
Regeneron Pharma (REGN)
$837.50+$3.46 (+0.41%)
REGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $834.04 | ||
Change | +$7.40 (+0.90%) | ||
Open | $835.74 | ||
High | $847.00 | ||
Low | $826.64 | ||
Previous Close | $826.64 | ||
Volume | 786,923 | ||
30-Day Average Volume | 827,826 | ||
1-Week Change | 3.92% | ||
1-Month Change | 23.67% | ||
1-Year Change | 42.21% | ||
3-Year Change | -0.29% | ||
5-Year Change | 26.93% | ||
Fundamentals | |||
Shares Outstanding | 101.1M | ||
Total Assets | $41.7B | ||
Market Cap | $83.6B | ||
Enterprise Value | $83.1B | ||
Period: QTR TTM FY | |||
Revenue | $1.6B | ||
Net Income | $1.3B | ||
Free Cash Flow | $572.8M | ||
EBIT | $1.5B | ||
EBITDA | $1.7B | ||
Net Working Capital | $12.9B | ||
EPS | $12.23 | ||
Enterprise Value/EBITDA | 50 | ||
Enterprise Value/Revenue | 51 | ||
P/B | 3 | ||
P/E | 68 | ||
PEG | 1 | ||
Price/Free Cash Flow | 147 | ||
Price/Operating Cash Flow | 104 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.45% | ||
Trailing Annual Dividend Yield | 0.44% | ||
Ex-Dividend Date | 08/18/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield